Package 68001-644-07

Brand: capecitabine

Generic: capecitabine
NDC Package

Package Facts

Identity

Package NDC 68001-644-07
Digits Only 6800164407
Product NDC 68001-644
Product ID 68001-644_498ba415-dab9-ce68-e063-6394a90af1b4
Description

120 TABLET, FILM COATED in 1 BOTTLE (68001-644-07)

Marketing

Marketing Status
Marketed Since 2025-04-22
Brand capecitabine
Generic capecitabine
Sample Package No

Linked Drug Pages (1)

Capecitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "498ba415-dab9-ce68-e063-6394a90af1b4", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0368001643061", "0368001644075"], "unii": ["6804DJ8Z9U"], "rxcui": ["200327", "200328"], "spl_set_id": ["88c5af84-900a-4372-b056-bfea70c129cf"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (68001-644-07)", "package_ndc": "68001-644-07", "marketing_start_date": "20250422"}], "brand_name": "Capecitabine", "product_id": "68001-644_498ba415-dab9-ce68-e063-6394a90af1b4", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68001-644", "generic_name": "Capecitabine", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Capecitabine", "active_ingredients": [{"name": "CAPECITABINE", "strength": "500 mg/1"}], "application_number": "ANDA210203", "marketing_category": "ANDA", "marketing_start_date": "20250422", "listing_expiration_date": "20271231"}